ABOUT
HUMAN CLINICAL TRIAL
SAFETY
DRUG DEVELOPMENT PROGRAM
NEUROPATHIC PAIN
TEAM
- CONTACT

Top 3

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

This website contains "forward looking” statements. Lateral Pharma Pty Ltd has tried to identify such forward-looking statements by use of such words as "expects,“ "intends,“ "hopes,“ "anticipates,“ "believes,“ "could,“ "may," "evidences“ and "estimates," and other similar expressions, but these words are not the exclusive means of identifying such statements. Such statements include, but are not limited to, any statements relating to Lateral's activities or drug development intellectual property, including the initiation, progress and outcomes of clinical trials and any other statements that are not historical facts. Such forward-looking statements involve risks and uncertainties, including, but not limited to, risks and uncertainties relating to the difficulties or delays in our plans to develop and potentially commercialise our product candidates, the timing of the initiation and completion of preclinical and clinical trials, the timing of patient enrolment and dosing in clinical trials, the timing of expected regulatory filings, the clinical utility and potential attributes and benefits of our drug product candidates, potential future out-licenses and collaborations, our intellectual property position and duration of our patent portfolio, the ability to procure additional sources of financing and other risks detailed from time to time. Such statements are based on management's current expectations, but actual results may differ materially due to various factors, including those risks and uncertainties mentioned or referred to in this presentation. Accordingly, you should not rely on those forward-looking statements as a prediction of actual future results. These materials are provided for information purposes only, and do not constitute an offer to sell or a solicitation of an offer to buy any securities. The materials provided are not a recommendation, or an offer, to make an investment in any company or securities or to participate in any transaction.